These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 32194366)
41. White matter connectivity reflects clinical and cognitive status in Huntington's disease. Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090 [TBL] [Abstract][Full Text] [Related]
42. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR; Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844 [TBL] [Abstract][Full Text] [Related]
43. Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study. Kim TH; Lee JH PLoS One; 2014; 9(11):e112512. PubMed ID: 25386854 [TBL] [Abstract][Full Text] [Related]
44. Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease. Picillo M; Santangelo G; Moccia M; Erro R; Amboni M; Prestipino E; Longo K; Vitale C; Spina E; Orefice G; Barone P; Pellecchia MT J Neural Transm (Vienna); 2016 Apr; 123(4):371-7. PubMed ID: 26739446 [TBL] [Abstract][Full Text] [Related]
45. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load. Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766 [TBL] [Abstract][Full Text] [Related]
46. Salivary FRAP as A Marker of Chronic Kidney Disease Progression in Children. Maciejczyk M; Szulimowska J; Taranta-Janusz K; Werbel K; Wasilewska A; Zalewska A Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31540400 [TBL] [Abstract][Full Text] [Related]
47. Association between serum uric acid and motor subtypes of Parkinson's disease. Lolekha P; Wongwan P; Kulkantrakorn K J Clin Neurosci; 2015 Aug; 22(8):1264-7. PubMed ID: 26055955 [TBL] [Abstract][Full Text] [Related]
48. Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases. Ni Z; Chen R Transl Neurodegener; 2015; 4():22. PubMed ID: 26579223 [TBL] [Abstract][Full Text] [Related]
49. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression. Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816 [TBL] [Abstract][Full Text] [Related]
50. A Case-Control Study of Salivary Redox Homeostasis in Hypertensive Children. Can Salivary Uric Acid be a Marker of Hypertension? Maciejczyk M; Taranta-Janusz K; Wasilewska A; Kossakowska A; Zalewska A J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32204502 [TBL] [Abstract][Full Text] [Related]
51. Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study. Chen D; Wei X; Zou J; Wang R; Liu X; Xu X; Lu J; Wang Z; Tang B; Wang B; Jin K; Wang Q Front Cell Neurosci; 2015; 9():247. PubMed ID: 26217177 [TBL] [Abstract][Full Text] [Related]